Document is current
Any future updates will be listed below
-
Authors
Pan, Leyun https://orcid.org/0000-0003-1116-7888
Sachpekidis, Christos
Strauss, Dimitrios S.
Hassel, Jessica C.
Dimitrakopoulou-Strauss, Antonia
-
Funding
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
- License Information
-
More Information
Article History
Received: 8 April 2026
Accepted: 11 June 2026
First Online: 20 June 2026
Declarations
Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Consent to participate: Informed consent was obtained from all participants enrolled in the study.
Consent to publish: Consent to publish has been received from all participants.
Competing interests: Jessica C. Hassel discloses Speaker: Amgen, Bristol-Myers Squibb, GSK, Immunocore, Merck Sharp and Dohme, Novartis Pharma, Pierre Fabre, Sanofi-Aventis U.S. LLC; Sunpharma; Research grant/contract: Bristol-Myers Squibb, Sanofi, Sunpharma; Consultant/Advisory Board: Bristol-Myers Squibb, GSK, Immunocore, Merck Sharp and Dohme, Novartis Pharma, Pierre Fabre Pharmaceuticals Inc., Philogen, Onkowissen, Sanofi-Aventis U.S. LLC, Sun Pharmaceutical Industries Inc. Christos Sachpekidis is an associate editor in this journal. Antonia Dimitrakopoulou-Strauss is a member of the editorial board of this journal. All other authors declare no conflicts of interest.
